Elecsys Testosterone Ii Immunoassay
Radioimmunoassay, Testosterones And Dihydrotestosterone. 510(k) K093421, from Roche Diagnostics Corp. (Indianapolis, IN). Product code CDZ, class 1.
As of Nov 20, 2026, K093421 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Apr 23, 2010 after 171 days, with no recalls tied to it in FDA's recall database.
- Review time: 171 days
- Recalls: 0
- Cited as a predicate by: 5 devices
- Elecsys Testosterone AssayK964889 · Boehringer Mannheim Corp. · Mar 18, 1997
- Elecsys Testosterone IIK211685 · Roche Diagnostics · May 6, 2022
- ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II (TSTII) Master Curve Material, ADVIA Centaur SHBG,…K151986 · Siemens Healthcare Diagnostics, Inc. · Jun 29, 2016
- Dimension Vista LOCI Total Testosterone Flex reagent cartridge, Dimension Vista Testosterone CalibratorK151529 · Siemens Healthcare Diagnostics, Inc. · Feb 11, 2016
- Liaison Testosterone; Liaison Testosterone Control SetK122793 · DiaSorin, Inc. · Jan 25, 2013
- Testosterone Test System; Calibrator; and Quality Control Material (Assayed and Unassayed)K120009 · Abbott Laboratories · Sep 11, 2012
- IDS-iSYS Total TestosteroneK252728 · Immunodiagnostic Systems Limited · Apr 15, 2026
- IDS-iSYS Free TestosteroneK240865 · Immunodiagnostic Systems Limited · Oct 23, 2024
- Access SHBGK233480 · Beckman Coulter, Inc. · Feb 8, 2024
- Access TestosteroneK223405 · Beckman Coulter, Inc. · Jan 13, 2023
- Elecsys Testosterone IIK211685 · Roche Diagnostics · May 6, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 3, 2009
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files